RoboScore
Not yet on file
Out of 100. Its robots, plus proof from customers and the press.
News bonus
Not yet on file
From the last 90 days, up to 15
RoboIndex
Not yet on file
No prior week
Rank change
Not yet on file
Not on a board yet
Physical AI for biological manufacturing
Is this your company? Claim it, free. Fix your record, add videos, see who looks.
Claim Multiply LabsMoney and customers
Raised
US$95.0M
Last raise · Series B · Sep 2026
Customers
None
No named customer yet
Backed by
MONEY RAISED
Funded · no products listed on Robolist yet
Bigger dot = bigger round. Hollow = amount not disclosed.
Funding rounds
- Sep 2026Series BUS$75.0MLead not disclosedNot disclosed7 outlets ↗
- Apr 2021Series AUS$20.0MLed by Casdin CapitalThe Robot Report ↗
Rounds recorded from January 2017. Every amount links to its source.
Suggest an editMultiply Labs designs and manufactures robotic biomanufacturing infrastructure, including robotic clusters and automated unit operations, for the pharmaceutical industry. Their systems integrate existing GMP instruments into closed, automated environments to scale throughput, reduce costs, and improve reliability and sterility in the production of advanced therapies.
Active products
0
Company facts
- Legal name
- Multiply Labs, Inc.
- HQ
- San Francisco, United States
- Stage
- Series B
- Website
- multiplylabs.com
Active robots by Multiply Labs
No robots indexed yet.
In the news
2 events · last 90 days
+3.1news bonus- Oct 6Multiply Labs Raises $75M in Series B Funding to Expand Robotic Drug Manufacturing
- Sep 17Multiply Labs Raises $75M in Series B Funding to Scale Robotic Drug Manufacturing
In the news
2 events · last 90 days
Why Multiply Labs has been in the news, across 5 outlets, collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore (the evidence half of the RoboIndex) and it can move a robot up a board by at most 15 points.